Immediate Impact
65 standout
Citing Papers
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of B.T. Li being referenced
164P Preliminary results from a phase I/II study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| B.T. Li | 76 | 60 | 15 | 36 | 19 | 100 | |
| William Lawler | 65 | 58 | 18 | 42 | 17 | 127 | |
| A. Martoni | 100 | 67 | 26 | 36 | 23 | 151 | |
| Laura Ginocchi | 115 | 66 | 25 | 46 | 16 | 177 | |
| G Garaventa | 60 | 60 | 35 | 29 | 20 | 177 | |
| Maitri Kalra | 74 | 31 | 25 | 62 | 22 | 146 | |
| Alice Baggi | 63 | 60 | 11 | 19 | 13 | 103 | |
| Xiangpeng Chu | 47 | 100 | 30 | 45 | 24 | 178 | |
| Isabel Echavarría | 78 | 45 | 42 | 41 | 14 | 129 | |
| Lokesh Viswanath | 59 | 46 | 8 | 20 | 14 | 113 | |
| Patrizia Guerrieri | 116 | 96 | 11 | 35 | 12 | 168 |
All Works
Login with ORCID to disown or claim papers
Loading papers...